Ebola and Marburg hemorrhagic fevers are acute viral diseases that often lead to severe illness and death in humans and other primates. The infections typically affect multiple organs in the body and are often accompanied by hemorrhage (bleeding). Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact.
Researchers in the NIAID Division of Intramural Research and at the Institute’s Vaccine Research Center as well as NIAID-supported scientists in external facilities are studying all aspects of Ebola and Marburg viruses, how they spread, and how they cause disease. Investigators seek better ways to diagnose and treat Ebola and Marburg fevers, including promising work on vaccines.
Study of Ebola Survivors Opens in Liberia—June 17, 2015
Media Availability: West African Ebola Virus Strain Less Virulent Than Prototype 1976 Strain—June 9, 2015
Statement: NIAID Recognizes Significant Milestone in Ebola Vaccine Study—May 7, 2015
Experimental Ebola Vaccine Safe, Prompts Immune Response—April 1, 2015
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial—March 26, 2015
Last Updated June 17, 2015